<?xml version="1.0" encoding="utf-8"?><svg:svg xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:svg="http://www.w3.org/2000/svg" version="1.1" width="595.22px" height="842px" preserveAspectRatio="none" viewBox="0 0 595.22 842"><svg:defs><svg:clipPath id="--clippath0" transform=""><svg:path d="M 0 0 L 595.22 0 L 595.22 842 L 0 842 Z" stroke-miterlimit="0" stroke-linecap="" stroke-linejoin="" stroke-width="1px" stroke-dasharray="" stroke-dashoffset="0px" fill="none" clip-rule="nonzero"></svg:path></svg:clipPath><svg:style type="text/css">@font-face { font-family: "g_d0_f1";; src: url(data:font/woff;base64,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); }  @font-face { font-family: "g_d0_f2";; src: url(data:font/woff;base64,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); }  @font-face { font-family: "g_d0_f3";; src: url(data:font/woff;base64,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); }  @font-face { font-family: "g_d0_f4";; src: url(data:font/woff;base64,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); }  @font-face { font-family: "g_d0_f5";; src: url(data:font/woff;base64,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); } </svg:style></svg:defs><svg:g transform="matrix(1 0 0 -1 0 842)"><svg:g transform=""><svg:path d="M 0 0 L 595.22 0 L 595.22 842 L 0 842 Z" stroke-miterlimit="0" stroke-linecap="" stroke-linejoin="" stroke-width="1px" stroke-dasharray="" stroke-dashoffset="0px" fill="none" clip-rule="nonzero"></svg:path></svg:g><svg:g clip-path="url(#clippath0)"><svg:g transform=""><svg:text transform="matrix(11 0 0 11 389.531 779.9031) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.258" x="0 0.577 1.063 1.401 2.098 2.584 3.018 3.577 3.747 4.264 4.758 4.964 5.45 5.602 5.952 6.474 6.994 7.308 7.646 7.828 8.262 8.444 8.961 9.483 9.833 10.345 10.695 11.2 11.382 11.904 12.218 12.74 13.054 13.236 13.67" font-family="g_d0_f1" font-size="1px" fill="rgb(43,46,52)">Farmacología, nutrición y dietética</svg:tspan></svg:text><svg:text transform="matrix(7.5 0 0 7.5 536.703 52.9521) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.25" x="0 0.556 1.112" font-family="g_d0_f2" font-size="1px" fill="rgb(43,46,52)">281</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 71.1496 756.5768) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.25" x="0 0.556 1.112 1.501 2.445 3.001 3.501 4.112 4.612 4.89 5.501 6.057 6.335 6.613 7.113 7.391 7.891 8.224 8.78 9.724 10.28 10.558 11.169 11.725 12.114 12.67 12.948 13.559 14.059 14.67 14.948 15.448 16.004 16.615 16.948 17.337 17.893" font-family="g_d0_f2" font-size="1px" fill="rgb(64,198,192)">Fármacos del sistema nervioso central</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 95.2945 712.4585) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.225" x="0 0.556 0.778 1.278 1.722 1.9213 2.4213 2.9213 3.1206 3.6206 4.1206 4.8426 5.0646 5.5646 5.7866 6.2306 6.5086 6.8416 7.3416 7.8416 8.0636 8.5636" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)">Vías de administración</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 180.334 712.5435) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.49 0.702 1.136 1.348 1.782 2.05 2.484" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">Vía oral</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 95.2945 694.7416) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.225" x="0 0.611 1.111 1.555 1.777 2.221 2.443 2.943 3.443 3.943 4.165 4.443 4.943 5.443 5.665 6.165" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)">Dosis habituales</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 180.334 694.3211) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.606" font-family="g_d0_f4" font-size="1px" fill="rgb(64,198,192)"> </svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 187.786 694.4316) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.222 0.666 0.888 1.277 1.499 1.943 2.165 2.387 2.609 3.053 3.497 3.941 4.219 4.663 5.107 5.551 5.773 6.44" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">Inicial: 160-325 mg</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 180.334 683.8211) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.606" font-family="g_d0_f4" font-size="1px" fill="rgb(64,198,192)"> </svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 187.786 683.9316) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.778 1.222 1.666 1.944 2.388 2.832 3.054 3.721 3.943 4.387 4.831 5.109 5.553 5.775 5.997 6.441 6.885 7.163 7.607 8.051 8.495 8.717 9.384 9.828 10.161 10.605 10.827" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">Mantenimiento: 75-325 mg/día</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 180.334 673.321) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.606" font-family="g_d0_f4" font-size="1px" fill="rgb(64,198,192)"> </svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 187.786 673.4315) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.556 1 1.389 1.611 2 2.222 2.666 3.11 3.554 3.776 4.22 4.664 5.053 5.275 5.664 6.108 6.33 6.552 6.996 7.44 7.662 8.106 8.384 8.606 8.828 9.272 9.661 10.105 10.327 10.549 10.938 11.16 11.604 12.048 12.326 12.548 12.826 13.27 13.548 14.215 14.437 14.826 15.27 15.492 15.714 16.158 16.602 17.046 17.268 17.935 18.379 18.712 19.156 19.434 19.878 20.1 20.544 20.988 21.266 21.71 22.099 22.321 22.543 22.932 23.154 23.598 23.82 24.209 24.653 25.097 25.375 25.819 26.263 26.707 27.096 27.54 27.818 28.04 28.484 28.706 29.15 29.483 29.927 30.149" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">Dosis analgésica (dolor leve) y antitérmica: 500 mg/4-6 horas, sin sobrepasar 3 g/día</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 95.2945 658.6125) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.225" x="0 0.278 0.778 1.278 1.5 2 2.5 3 3.222 3.722 4.222 4.722" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)">Indicaciones</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 180.334 658.191) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.606" font-family="g_d0_f4" font-size="1px" fill="rgb(64,198,192)"> </svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 187.786 658.3015) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.222 0.778 1.556 1.778 2 2.444 2.888 3.332 3.554 3.998 4.442 4.664 4.886 5.33 5.774 6.163 6.441 6.885 7.329 7.551" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">IAM, angina inestable</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 180.334 647.691) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.606" font-family="g_d0_f4" font-size="1px" fill="rgb(64,198,192)"> </svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 187.786 647.8015) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.444 0.722 1.166 1.388 1.61 1.832 2.276 2.665 2.887 3.276 3.498 3.942 4.386 4.608 4.83 5.386 6.164 6.386 6.608 6.886 7.33 7.552 7.996 8.274 8.718 8.996 9.274 9.718 9.94 10.384 10.828 11.05 11.494 11.938 12.327 12.549 12.993 13.437 13.715 14.159 14.548 14.77 15.159 15.603 16.047 16.269 16.713 17.157 17.601 17.823 18.267 18.711 18.933 19.377 19.821 20.043 20.487 20.931 21.32 21.764 22.208 22.43 22.652 23.096 23.54 23.929 24.207 24.651 25.095 25.317 25.761" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">Proﬁ laxis de IAM, reinfarto en pacientes con angina de pecho inestable </svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 180.334 637.191) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.606" font-family="g_d0_f4" font-size="1px" fill="rgb(64,198,192)"> </svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 187.786 637.3015) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.556 0.778 1 1.389 1.611 2.055 2.277 2.666 2.888 3.332 3.61 4.054 4.721 5.165 5.443 5.665 6.054 6.498 6.72 7.164 7.608 7.83 8.052 8.496 8.94 9.162 9.606 9.884 10.106 10.495 10.717 10.995 11.273 11.717 11.995 12.439 13.106 13.328 13.772 14.216 14.494 14.938 15.16 15.604 16.048 16.27 16.492 16.936 17.158 17.38 17.602 18.046 18.49 18.768" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">Alivio sintomático del dolor y tratamiento de la ﬁ ebre</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 95.2945 622.4825) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.225" x="0 0.611 1.111 1.611 1.833 2.333" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)">Acción</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 180.334 622.5685) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.556 0.945 1.223 1.667 2.111 2.333 2.777 2.999 3.443 3.665 4.054 4.498 4.72 4.942 5.386 5.83 6.108 6.33 6.608 7.052 7.33 7.552 7.941 8.385 8.607 8.829 9.273 9.717 9.939 10.383 10.605 11.049 11.493 11.937 12.381 12.603 13.047 13.491 13.713 13.991 14.435 14.713 15.38 15.824 16.046 16.49 16.934 17.156 17.545 17.989 18.211 18.655 19.044 19.322 19.544 19.933 20.377 20.599 20.821 21.265 21.487 21.931 22.375 22.708 22.93 23.597 24.041 24.263 24.652 24.874 25.263 25.485 25.929 26.373 26.762 26.984 27.428 27.872 28.316 28.76 29.149 29.593 29.815 30.037 30.537 31.093 31.593 31.815 32.037 32.259 32.703 33.147 33.591 33.813 34.035 34.479 34.757 35.201 35.479 35.868 36.09 36.534 36.978 37.422 37.644 38.088 38.532 38.754 38.976 39.42" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">Actúa a nivel periférico inhibiendo de forma no selectiva la enzima ciclooxigenasa (COX), que interviene en la </svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 180.334 612.06845) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.278 0.556 1 1.444 1.833 2.111 2.555 2.833 3.5 3.944 4.333 4.555 4.999 5.443 5.665 6.109 6.553 6.775 7.219 7.608 7.83 8.274 8.718 8.94 9.384 9.662 10.106 10.55 10.994 11.216 11.66 12.104 12.548 12.77 13.159 13.603 13.825 14.269 14.713 14.935 15.379 15.657 16.101 16.49 16.768 17.212 17.601 17.823 18.212 18.434 18.656 19.1 19.544 19.933 20.155 20.377 20.599 21.043 21.432 21.654 22.098 22.376 22.82 23.209 23.487 23.931 24.375 24.597 25.041 25.485 25.929 26.151 26.595 27.039 27.428 27.65 27.872 28.316 28.872 29.094 29.316 29.705 29.927 30.149 30.593 30.982 31.204 31.482 31.76 32.204 32.871 33.315 33.759 34.148 34.592 35.036 35.48 35.869 36.091 36.313 36.757 37.257 37.479 37.701 37.923 38.367 38.589 38.811 39.255" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">transformación de ácido araquidónico en prostaciclinas, las prostaglandinas (PG) y los tromboxanos (TX). Ello </svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 180.334 601.5684) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.222 0.666 0.888 1.332 1.61 2.054 2.498 2.942 3.22 3.609 3.831 4.275 4.719 5.163 5.385 5.829 6.273 6.717 6.939 7.383 7.772 8.161 8.383 8.827 9.271 9.493 9.937 10.381 10.825 11.047 11.491 11.935 12.324 12.546 12.935 13.379 13.601 13.823 14.267 14.711 14.989 15.211 15.655 16.099 16.377 16.821 17.265 17.709 18.153 18.431 18.875 19.097 19.541 19.763 20.207 20.651 21.095 21.539 21.817 22.261 22.539 22.761 23.205 23.427 23.649 24.093 24.537 24.815 25.037 25.315 25.759 26.037 26.704 26.926 27.315 27.759 27.981 28.37 28.592 29.036 29.48 29.758 29.98 30.202 30.646 30.868 31.09 31.534 32.201 32.645 32.923 33.367 33.645 33.867" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">le proporciona una acción analgésica, antiagregante plaquetaria, antitérmica y antiinﬂ amatoria</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 95.2945 586.6975) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.225" x="0 0.5 0.778 1.278 1.778 2.056 2.556 3 3.222 3.666 4.166 4.666 5.166 5.666 6.166 6.666 6.999 7.221 7.721" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)">Efectos secundarios</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 180.334 586.7835) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.222 0.5 0.778 1 1.278 1.722 2.111 2.333 2.777 3.221 3.443 3.887 4.331 4.72 4.998 5.276 5.72 5.942 6.386 6.664 7.108 7.497 7.775 7.997 8.441 8.885 9.107 9.329 9.551 9.995 10.273 10.717 11.161 11.55 11.772 12.216 12.66 13.104 13.493 13.715 14.104 14.548 14.826 15.27 15.714 16.158 16.602 16.991 17.213 17.435 17.879 18.101 18.323 18.545 18.934 19.378 19.6 19.878 20.322 20.766 20.988 21.266 21.71 22.099 22.543 22.765 23.043 23.487 23.765 24.209 24.487 24.709 25.153 25.375 25.597 25.986 26.43 27.097 27.541 27.985 28.207 28.651 29.095 29.484 29.706 30.15 30.372 30.594 30.983 31.427 31.705 31.983 32.205 32.649 33.093 33.482 33.704 33.926 34.37 34.814 35.258 35.702 35.98 36.202 36.48 36.702" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">Irritación gastrointestinal, erupciones cutáneas, diﬁ cultad respiratoria, somnolencia, vértigos, hepatitis</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 95.2945 570.6175) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.225" x="0 0.278 0.778 1.056 1.556 1.889 2.389 2.889 3.389 3.611 4.111 4.611 5.111" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)">Interacciones</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 180.334 570.196) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.606" font-family="g_d0_f4" font-size="1px" fill="rgb(64,198,192)"> </svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 187.786 570.3065) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.556 1 1.278 1.5 1.889 2.333 2.777 3.221 3.665 3.887 4.331 4.775 5.053 5.497 5.886 6.108 6.552 6.83 7.274 7.496 7.94 8.329 8.551 8.94 9.162 9.718 10.274" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">Anticoagulantes orales y ADO</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 180.334 559.696) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.606" font-family="g_d0_f4" font-size="1px" fill="rgb(64,198,192)"> </svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 187.786 559.8065) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.778 1.222 1.5 1.944 2.222 2.5 2.944 3.333 3.777 4.166" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">Metotrexaco</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 180.334 549.196) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.606" font-family="g_d0_f4" font-size="1px" fill="rgb(64,198,192)"> </svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 187.786 549.3065) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.389 0.833 1.277 1.499 1.777 2.221 2.443 2.887 3.331 3.553 3.775 4.053 4.497 4.941 5.385 5.774 6.218 6.44 6.829 7.273 7.495 7.939 8.217 8.661 9.05 9.328 9.772" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">Fenitoína (reduce su efecto)</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 95.294099 534.4876) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.225" x="0 0.556 0.889 1.389 1.889 2.389 2.889 3.389 3.611 4.111 4.611 5.111 5.555" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)">Precauciones </svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 95.294099 523.98755) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.225" x="0 0.5 0.944 1.444 1.944 2.444 2.666 3.166 3.388 3.888" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)">especiales</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 180.334 534.067) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.606" font-family="g_d0_f4" font-size="1px" fill="rgb(64,198,192)"> </svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 187.786 534.1775) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.601 1.035 1.247 1.681 2.115 2.772 2.984 3.418 3.63 4.009 4.277 4.545 4.979 5.247 5.459 5.838 6.272 6.706 6.918 7.186 7.62 7.888 8.545 8.979 9.358 9.792 10.171 10.383 10.817 11.251 11.519 11.953 12.387 12.766 12.978 13.412 13.624 14.281 14.715 15.149 15.417 15.851 16.063 16.497 16.709 17.088 17.522 17.79 18.224 18.658 19.092 19.526 19.738 20.117 20.551" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">No administrar con fármacos potencialmente ulcerogénicos</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 180.334 523.567) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.606" font-family="g_d0_f4" font-size="1px" fill="rgb(64,198,192)"> </svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 187.786 523.6775) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.434 0.868 1.247 1.459 1.893 2.327 2.595 3.029 3.408 3.62 4.054 4.488 5.145 5.579 5.847 6.059 6.271 6.483 6.862 7.296 7.675 7.887 8.266 8.478 8.912 9.18 9.448 9.882 10.261 10.473 10.907 11.175 11.609 11.988 12.422 12.801 13.235 13.614 13.826 14.26 14.694 15.351 15.785 16.053 16.321 16.755 17.189 17.401 17.78 18.214" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">Pacientes hemofílicos y otros procesos hemorrágicos</svg:tspan></svg:text><svg:text transform="matrix(9.5 0 0 9.5 91.4969 735.207) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.244" x="0 0.631 0.993 1.209 1.757 2.196 2.412 2.951 3.167 3.711 4.09 4.602 5.041 5.379 5.595 6.092 6.636 6.821 7.2 7.712 8.151 8.367 8.896 9.44 9.819 10.331 10.77 11.318 11.656 11.872 12.084 12.624 13.136 13.348 13.564 14.003 14.239 14.451 14.667 15.106" font-family="g_d0_f5" font-size="1px" fill="rgb(64,198,192)">Principio activo: ácido acetilsalicílico</svg:tspan></svg:text><svg:text transform="matrix(9.5 0 0 9.5 87.7055 475.669) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.244" x="0 0.631 0.993 1.209 1.757 2.196 2.412 2.951 3.167 3.711 4.09 4.602 5.041 5.379 5.595 6.092 6.636 6.821 7.2 7.739 8.251 8.589 9.101 9.54 10.088 10.426 10.938 11.663 12.207 12.419 12.93 13.469 13.823 14.367 14.906 15.418 15.756 16.268 16.707 17.255 17.593 18.105 18.83 19.374" font-family="g_d0_f5" font-size="1px" fill="rgb(64,198,192)">Principio activo: paracetamol/proparacetamol</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 91.8409 452.8875) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.225" x="0 0.556 0.778 1.278 1.722 1.9214 2.4214 2.9214 3.1208 3.6208 4.1208 4.8428 5.0648 5.5648 5.7868 6.2308 6.5088 6.8418 7.3418 7.8418 8.0638 8.5638" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)">Vías de administración</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 176.88 452.9725) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.212 0.646 0.914 1.182 1.616 1.995 2.429 2.863 3.297 3.676 4.11 4.322 4.534 4.968 5.236 5.67" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">Intravenosa, oral</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 91.8409 436.3045) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.225" x="0 0.611 1.111 1.555 1.777 2.221 2.443 2.943 3.443 3.943 4.165 4.443 4.943 5.443 5.665 6.165" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)">Dosis habituales</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 176.88 436.3895) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.424 0.848 1.106 1.364 1.788 2.157 2.359 2.783 3.207 3.409 3.611 4.091 4.293 4.717 5.141 5.343 5.767 6.191 6.393 7.04 7.242 7.666 8.09 8.348 8.772 9.141 9.343 9.767 10.191 10.393 10.817 11.241 11.499 11.923 12.347 12.771 12.973 13.62 13.822 14.024 14.448 14.872 15.074 15.443 15.867 16.291 16.549 16.973 17.175 17.387 17.599 17.968 18.17 18.594 18.796 19.22 19.644 19.846 20.215 20.639 20.841 21.265 21.467 21.891 22.093 22.517 22.886 23.31 23.679 24.103 24.527 24.951 25.153 25.577 25.779 25.981 26.405 27.163 27.365 27.567 27.991 28.193 28.617 29.041 29.41 29.612 29.981 30.183 30.607 31.031 31.233 31.657 31.915 32.339 32.541 32.965 33.167 33.591 34.015 34.217 34.641 34.899 35.323 35.747 36.171 36.429 36.853 37.222 37.646 37.904 38.328 38.975 39.399 39.621" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">Perfusión IV de 15 minutos en 50-125 ml de suero ﬁ siológico o glucosado al 5%, a dosis de 1-2 g de proparacetamol </svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 176.88 426.1895) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.369 0.793 1.217 1.641 1.843 2.267 2.525 2.949 3.151 3.575 3.999 4.257 4.681 5.05 5.252 5.454 5.823 6.247 6.671 7.095 7.519 7.721 7.923 8.347 8.549 8.751 9.175 9.433 9.857 10.281 10.65 10.852 11.276 11.7 12.124 12.326 12.75 13.174 13.376 13.578 14.002 14.426 14.628 15.052 15.24 15.442 15.644 16.013 16.437 16.639 17.063 17.487 17.856 18.058 18.427 18.629 19.276 19.7 20.069 20.271 20.918 21.342 21.544 21.968 22.337 22.539 22.963 23.387 23.589 24.013 24.215 24.639 24.841 25.265 25.689 25.891 26.315 26.573 26.997 27.421 27.845 28.103 28.527 28.896 29.32 29.578 30.002 30.649 31.073 31.275 31.477 31.901 32.103 32.305 32.729 32.931 33.355 33.557 33.759 34.183 34.607 34.809 35.178 35.602 35.971 36.395 36.597 37.021 37.465" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">cada 4-6 horas, según la intensidad del dolor. La dosis máxima es de 8 g de proparacetamol al día. En caso de </svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 176.88 415.9895) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.202 0.626 0.995 1.419 1.631 1.843 2.212 2.414 2.838 3.262 3.631 3.833 4.257 4.459 4.717 5.141 5.565 5.989 6.191 6.393 6.595 7.019 7.221 7.423 7.625 8.049 8.307 8.731 8.989 9.358 9.782 9.984 10.408 10.61 11.034 11.458 11.66 12.084 12.508 13.155 13.357 13.781 13.983 14.352 14.61 14.868 15.292 15.661 15.863 16.287 16.711 16.913 17.282 17.706 17.964 18.388 18.59 19.014 19.216 19.418 20.065 20.489 20.913 21.337 21.706 21.908 22.332 22.756 22.958 23.382 23.584 24.008 24.432 24.69 25.114 25.483 25.685 25.887 26.367 26.569 26.993 27.195 27.619 27.877 28.301 28.503 28.705 28.907 29.331 29.533 29.957 30.215 30.639 30.841 31.265 31.578 32.002 32.26 32.684 32.942 33.366 33.568 33.992 34.416 34.674 35.098" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">insuﬁ ciencia renal, el intervalo de administración será al menos de 8 horas. Vía oral, 0,5-1 g/4-6-8 horas</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 91.8409 400.5195) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.225" x="0 0.278 0.778 1.278 1.5 2 2.5 3 3.222 3.722 4.222 4.722" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)">Indicaciones</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 176.88 400.6055) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.389 0.611 1.055 1.499 1.777 2.221 2.443 2.832 3.054 3.498 3.942 4.164 4.608 4.886 5.108 5.775 6.219 6.663 7.107 7.385 7.829 8.273 8.717 8.939 9.383 9.605 9.994 10.438 10.827 11.271 11.549 11.993 12.215 12.437 12.826 13.27 13.492 13.936 14.158 14.602 14.824 15.268 15.657 16.101 16.49 16.712 17.156 17.6 18.044 18.266 18.71 18.932 19.376 19.82 20.042 20.486 20.875 21.319 21.763" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">Fiebre y dolor moderado a severo, solo o asociado a opiáceos</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 91.8409 385.7345) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.225" x="0 0.611 1.111 1.611 1.833 2.333" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)">Acción</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 176.88 385.314) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.606" font-family="g_d0_f4" font-size="1px" fill="rgb(64,198,192)"> </svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 184.332 385.4245) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.556 1 1.444 1.666 2.11 2.554 2.943 3.165 3.554 3.998 4.22 4.609 4.831 5.275 5.719 5.997 6.219 6.663 6.885 7.163 7.607 7.885 8.107 8.496 8.94 9.162 9.384 9.606 10.05 10.494 10.716 11.16 11.604 11.826 12.048 12.492 12.714 13.158 13.714 13.936 14.38 14.824 15.046 15.49 15.712 15.934 16.323 16.545 16.934 17.212 17.656 18.323 18.767 18.989 19.433 19.877 20.155 20.544 20.766 21.21 21.599 22.043 22.265 22.654 23.098 23.542 23.82 24.098 24.542 24.764 24.986 25.208 25.708 26.319 26.819" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">Analgésico y antipirético. Inhibe la PG en el sistema nervioso central (SNC)</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 176.88 374.514) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.606" font-family="g_d0_f4" font-size="1px" fill="rgb(64,198,192)"> </svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 184.332 374.6245) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.556 1 1.667 1.889 2.333 2.555 2.944 3.222 3.5 3.944 4.333 4.555 4.999 5.443 5.665 6.109 6.553 6.831 7.275 7.719 7.997 8.441 8.719 9.163 9.385 9.607 10.051 10.495 10.939 11.161 11.55 11.994 12.438 12.827 13.049 13.438 13.716 14.16 14.382 14.826 15.27 15.492 15.936 16.38 16.824 17.046 17.713 18.157 18.379 18.823 19.212 19.656 19.878 20.322 20.544 20.988 21.266 21.71 22.099 22.543 22.821 23.21 23.654 23.932 24.376 24.598 25.042 25.486 25.93 26.374 27.041 27.263 27.707 28.151 28.595 29.039 29.261 29.705 29.983 30.427 30.871 31.315 31.593 32.037 32.426 32.87 33.148 33.592 34.259 34.703 34.925 35.147 35.591 36.035 36.479 36.701 37.09 37.534" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">Administración parenteral que consiste en una molécula precursora denominada proparacetamol que se </svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 185.3843 364.4245) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.389 0.833 1.277 1.666 1.888 2.332 2.61 2.888 3.332 3.554 3.832 4.276 4.72 4.942 5.386 5.83 6.497 6.941 7.385 7.663 8.107 8.329 8.551 8.995 9.439 9.661 10.05 10.494 10.938 11.382 11.66 12.104 12.326 12.548 12.992 13.436 13.658 14.102 14.546 14.824 15.268 15.657 16.101 16.379 16.823 17.49 17.934 18.156 18.378 18.6 19.044 19.488 19.766 19.988 20.21 20.654 21.043 21.265 21.709 22.098 22.376 22.82 23.098 23.542 23.931 24.375 24.764 24.986 25.43 25.652 26.096 26.485 27.152 27.596 27.874 28.096 28.485 28.929" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">convierte rápidamente, en sangre, en paracetamol, por las esterasas plasmáticas</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 91.8409 349.6055) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.225" x="0 0.5 0.778 1.278 1.778 2.056 2.556 3 3.222 3.666 4.166 4.666 5.166 5.666 6.166 6.666 6.999 7.221 7.721" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)">Efectos secundarios</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 176.88 349.6905) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.5 0.944 1.222 1.5 1.722 2.166 2.61 2.832 3.054 3.498 3.942 4.386 4.775 5.219 5.663 6.052 6.274 6.718 6.94 7.384 7.606 8.05 8.494 8.772 9.216 9.66 10.049 10.271 10.715 11.159 11.381 11.825 12.103 12.381 12.825 13.103 13.325 13.769 13.991 14.213 14.435 14.879 15.268" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">Vértigo, náuseas e hipotensión arterial leve</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 91.8409 334.8205) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.225" x="0 0.278 0.778 1.056 1.556 1.889 2.389 2.889 3.389 3.611 4.111 4.611 5.111" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)">Interacciones</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 176.88 334.9055) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.389 0.833 1.111 1.778 2.222 2.611 3.055 3.444 3.666 4.055 4.499 4.943 5.165 5.832 6.276 6.554 6.998 7.442 7.886 8.108 8.33 8.719 9.386 9.83 10.052 10.496 10.94 11.384 11.828 12.106 12.328 12.717 13.161 13.383 13.605 14.049 14.493 14.771 14.993 15.437 15.659 16.103 16.77 17.214 17.436 17.88 18.102 18.324 18.768 19.212 19.49 19.712 20.101 20.545 20.989 21.433 21.877 22.099 22.543 22.987 23.265 23.709 24.098 24.32 24.764 25.042 25.486 25.708 26.152 26.541 26.763 26.985 27.429 27.651 28.04 28.484 28.928 29.372 29.594 29.816 30.26 30.538 30.76 30.982 31.204 31.593 32.037 32.259" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">Fármacos con metabolismo hepático (por ejemplo, anticoagulantes orales, alcohol etílico, </svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 176.88 324.7055) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.444 0.888 1.166 1.388 1.777 2.221 2.665 3.054 3.498 3.72 4.109 4.331 4.775 5.219 5.663 6.107 6.385 6.829 7.218 7.44 7.662 8.051 8.273 8.717 8.995 9.439 9.883 10.161 10.605 11.049 11.271 11.66 12.104 12.326 12.548 12.77 13.214 13.603 13.881 14.159 14.603 15.047 15.491 15.935 16.379 16.768 16.99 17.212 17.656 17.878 18.322 18.6 19.044 19.322 19.544 19.933 20.377 20.766 20.988 21.432 21.876 22.098 22.32 22.764 23.153 23.597 23.819 24.041 24.263 24.652 25.096 25.54 25.762 26.206 26.539 26.761 27.205 27.649 27.871 28.093 28.537 28.815 29.259 29.703 30.147 30.591 31.035 31.257 31.701 31.923 32.145 32.367 32.589" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">anticonvulsionantes, cloranfenicol, estrógenos, diuréticos del asa, isoniazida, propanolol...)</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 91.840904 309.8356) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.225" x="0 0.556 0.889 1.389 1.889 2.389 2.889 3.389 3.611 4.111 4.611 5.111 5.555" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)">Precauciones </svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 91.840904 299.6356) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.225" x="0 0.5 0.944 1.444 1.944 2.444 2.666 3.166 3.388 3.888" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)">especiales</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 176.88 309.414) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.606" font-family="g_d0_f4" font-size="1px" fill="rgb(64,198,192)"> </svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 184.332 309.5245) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.601 1.035 1.414 1.682 2.116 2.495 2.707 3.086 3.298 3.732 4.166 4.6 5.034 5.302 5.514 5.893 6.327 6.706 6.918 7.352 7.564 7.998 8.432 8.811 9.023 9.402 9.614 10.271 10.705 11.084 11.296 11.675 12.109" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">Necrosis hepáticas a dosis masivas</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 176.88 298.6141) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.606" font-family="g_d0_f4" font-size="1px" fill="rgb(64,198,192)"> </svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 184.332 298.7246) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.4341 0.8682 1.081 1.4601 1.8942 2.2733 2.7074 2.9202 3.3543 3.7884 4.0012 4.2133 4.6474 4.9155 5.3496 5.7287 5.9408 6.3199 6.754 7.1331 7.3452 7.7793 8.2134 8.4255 8.6383 9.0724 9.5065 9.7746 9.9867 10.4208 10.8549 11.123 11.5571 11.7699 12.204 12.5831 13.0172 13.4513 13.8304 14.0425 14.2596 14.4724 14.8515 15.2856 15.4984 15.7105 16.1446 16.4127 16.8468 17.2259 17.66 17.9281 18.1402 18.3523 18.7314 18.9435 19.3226 19.5907 20.0248 20.2369 20.671 21.1051" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">En caso de intoxicación, antídoto especíﬁ co (n-acetilcisteína)</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 91.2427 231.6175) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.225" x="0 0.556 0.778 1.278 1.722 1.9213 2.4213 2.9213 3.1206 3.6206 4.1206 4.8426 5.0646 5.5646 5.7866 6.2306 6.5086 6.8416 7.3416 7.8416 8.0636 8.5636" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)">Vías de administración</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 176.282 231.7025) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.212 0.646 0.914 1.182 1.616 1.995 2.429 2.863 3.297 3.676 4.11 4.322 4.534 4.746 5.18 5.448 5.716 6.15 6.807 7.241 7.62 7.999 8.433 8.645 9.079 9.277 9.489 9.701 10.135 10.403 10.837" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">Intravenosa, intramuscular, oral</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 91.2427 213.9015) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.225" x="0 0.611 1.111 1.555 1.777 2.221 2.443 2.943 3.443 3.943 4.165 4.443 4.943 5.443 5.665 6.165" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)">Dosis habituales</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 176.282 213.48) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.606" font-family="g_d0_f4" font-size="1px" fill="rgb(64,198,192)"> </svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 183.734 213.5905) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.556 1 1.444 1.666 2.11 2.777 3.221 3.665 3.887 4.109 4.553 4.775 4.997 5.441 5.663 6.107 6.329 6.551 6.995 7.439 7.717 7.939 8.328 8.55 8.994 9.216 9.438 10.216 10.438 10.882 11.16 11.604 11.882 12.326 12.77 13.214 13.658 13.88 14.324 14.546 14.768 15.268 15.49 15.712 16.156 16.6 16.878 17.322 17.544 17.766 18.21 18.432 19.099 19.321 19.765 20.209 20.487 20.931 21.32 21.542 21.764 22.153 22.597 23.041 23.485 23.707 24.151 24.373" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">Una ampolla (2 g) por vía IM profunda o IV lenta (3 minutos) cada 8 h</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 176.282 202.68) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.606" font-family="g_d0_f4" font-size="1px" fill="rgb(64,198,192)"> </svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 183.734 202.7905) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.444 0.888 1.11 1.554 1.998 2.22 2.664 2.942 3.164 3.608 4.052 4.441 4.885 5.107 5.551 5.995 6.217 6.606 7.05 7.272 7.716 8.049 8.493 8.771 9.215 9.437 9.881 10.548 10.992 11.436 11.658 11.88 12.324 12.546 12.935 13.379 13.823 14.267 14.489 14.933 15.211 15.655 15.877 16.321 16.543 16.765 17.265 17.487 17.931 18.153 18.597 18.875 19.319" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">En dolor oncológico 1/2-1 ampolla cada 6-8 h. Vía oral</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 91.2427 187.9715) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.225" x="0 0.278 0.778 1.278 1.5 2 2.5 3 3.222 3.722 4.222 4.722" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)">Indicaciones</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 176.282 188.0565) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.556 1 1.222 1.666 1.944 2.166 2.61 3.054 3.498 3.942 4.386 4.608 5.052 5.496 5.885 6.163 6.607 7.051 7.495 7.773 8.217 8.495 8.939 9.217 9.439 9.883 10.105 10.549 10.771 11.215 11.659 12.048 12.326 12.604 13.048 13.492 14.159 14.603 14.881 15.103 15.492 15.936 16.158 16.38 16.824 17.268 17.49 17.934 18.212 18.434 18.878 19.322 19.544 19.822 20.044 20.488 20.932 21.154 21.543 21.987 22.209 22.431 22.82 23.264 23.486 23.708 23.93 24.152 24.596 25.04 25.318 25.762 25.984 26.428 26.872 27.316 27.538 27.982 28.426 28.648 28.926 29.37 29.759 30.203 30.647 31.091 31.535 31.979 32.201 32.645 32.867 33.311 33.589 33.867 34.311 34.7 34.922 35.366 35.81 36.088 36.31 36.588 37.032 37.31 37.977 38.199 38.588 39.032" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">Dolor agudo postoperatorio o postraumático, dolor de tipo cólico, ﬁ ebre que no responde a otros antitérmicos</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 91.2427 173.1865) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.225" x="0 0.611 1.111 1.611 1.833 2.333" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)">Acción</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 176.282 173.2725) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.556 1 1.444 1.666 2.11 2.554 2.943 3.165 3.554 3.998 4.22 4.442 4.886 5.33 5.608 5.83 6.274 6.496 6.774 7.218 7.496 7.718 8.107 8.551 8.773 9.162 9.384 9.828 10.217 10.661 11.105 11.494 12.161 12.605 12.827 13.049 13.327 13.549 13.938" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">Analgésico, antipirético y espasmolítico</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 91.2427 158.4015) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.225" x="0 0.5 0.778 1.278 1.778 2.056 2.556 3 3.222 3.666 4.166 4.666 5.166 5.666 6.166 6.666 6.999 7.221 7.721" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)">Efectos secundarios</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 176.282 158.4876) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.5 0.944 1.222 1.5 1.722 2.166 2.61 2.832 3.054 3.498 3.942 4.386 4.775 5.219 5.663 6.052 6.274 6.718 6.94 7.384 7.606 8.05 8.494 8.772 9.216 9.66 10.049 10.271 10.715 11.159 11.381 11.825 12.103 12.381 12.825 13.103 13.325 13.769 13.991 14.213 14.435 14.879 15.268" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">Vértigo, náuseas e hipotensión arterial leve</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 91.2427 142.3215) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.225" x="0 0.278 0.778 1.056 1.556 1.889 2.389 2.889 3.389 3.611 4.111 4.611 5.111" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)">Interacciones</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 176.282 141.9) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.606" font-family="g_d0_f4" font-size="1px" fill="rgb(64,198,192)"> </svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 183.734 142.0105) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.5 0.722 1.166 1.555 1.999 2.443 2.665 3.109 3.553 4.22 4.664 5.108 5.386 5.83 6.274 6.718 6.94 7.384 7.828 8.05 8.328 8.772 9.216 9.605 9.994 10.216 10.66 11.104 11.548 11.937 12.159 12.603 13.047 13.491 13.713 13.935 14.157 14.601 14.99 15.268 15.49 15.879 16.323 16.712 16.934 17.323 17.545 17.989 18.433 18.711 19.155 19.599 20.043 20.265 20.709 21.098 21.32 21.598 22.042 22.431 22.653" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">Riesgo aumentado de reacciones anaﬁ lácticas y agranulocitosis</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 176.282 131.1) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.606" font-family="g_d0_f4" font-size="1px" fill="rgb(64,198,192)"> </svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 183.734 131.2105) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.556 0.778 1.222 1.666 1.944 2.388 2.832 3.221 3.443 3.887" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">Hipotensión</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 91.24295 116.3916) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.225" x="0 0.556 0.889 1.389 1.889 2.389 2.889 3.389 3.611 4.111 4.611 5.111 5.555" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)">Precauciones </svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 91.24295 106.191599) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.225" x="0 0.5 0.944 1.444 1.944 2.444 2.666 3.166 3.388 3.888" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)">especiales</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 176.282 115.9711) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.606" font-family="g_d0_f4" font-size="1px" fill="rgb(64,198,192)"> </svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 183.734 116.0816) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.2121 0.6462 0.9143 1.3484 1.6165 1.8846 2.3187 2.7528 3.1319 3.344 3.7781 4.2122 4.4247 4.6368 5.0709 5.728 6.1621 6.5962 6.8083 7.2424 7.5105 7.9446 8.1571 8.5912 9.0253 9.2374 9.4499 9.718 9.9861 10.4202 10.6883 11.1224 11.7795 11.9916 12.4257 12.8598 13.1279 13.562 13.7745 14.1536 14.3657 14.5782 15.0123 15.4464 15.8805 16.1486 16.5827 16.9618 17.3959 17.6084 18.0425 18.2546 18.6887 19.1228 19.5569 19.7694 20.1485 20.3606 20.7947 21.2288 21.6629 21.8754 22.3095 22.522 22.9011 23.1132 23.5473 23.8154 24.2495 24.9066 25.3407 25.5532 25.9873 26.4214 26.6339 27.068 27.5021 27.9362 28.1533 28.3658 28.5779 29.012 29.3911 29.6032 29.9923" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">Interrupción inmediata del tratamiento si aparece algún signo o síntoma de anaﬁ laxis </svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 176.282 105.171) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.606" font-family="g_d0_f4" font-size="1px" fill="rgb(64,198,192)"> </svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 183.734 105.2815) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.434 0.868 1.247 1.459 1.893 2.327 2.595 3.029 3.408 3.62 3.999 4.433 4.867 5.079 5.463 6.009 6.221 6.6 6.812 7.191 7.459 7.893 8.105 8.317 8.696 9.13 9.342 9.776 10.21 10.478 10.69 11.124 11.558 11.992 12.426 12.638 13.072 13.284 13.718 14.152 14.364 14.798 15.232 15.666 15.878 16.535 17.192 17.738" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">Pacientes con TA sistólica por debajo de 100 mmHg</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 176.282 94.371) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.606" font-family="g_d0_f4" font-size="1px" fill="rgb(64,198,192)"> </svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 183.734 94.4815) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.434 0.868 1.247 1.459 1.893 2.327 2.595 3.029 3.408 3.62 3.999 4.433 4.867 5.079 5.458 5.67 5.938 6.317 6.751 6.963 7.397 7.776 7.988 8.422 8.856 9.068 9.28 9.714 10.148 10.527 10.795 11.229 11.663 11.875" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">Pacientes con circulación inestable</svg:tspan></svg:text><svg:text transform="matrix(9.5 0 0 9.5 87.4451 253.657) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.244" x="0 0.631 0.993 1.209 1.757 2.196 2.412 2.951 3.167 3.711 4.09 4.602 5.041 5.379 5.595 6.092 6.636 6.821 7.2 7.925 8.473 8.811 9.323 10.048 10.264 10.725" font-family="g_d0_f5" font-size="1px" fill="rgb(64,198,192)">Principio activo: metamizo</svg:tspan></svg:text></svg:g></svg:g></svg:g></svg:svg>